Related Experiment Video
Updated: Jul 4, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy:
Eduardo Payá1, Francisco Marín, Josefa González
1Department of Cardiology, Hospital General Universitario, Alicante, Spain.
Insights
Late gadolinium enhancement (LGE) is common in hypertrophic cardiomyopathy (HCM) and linked to increased wall thickness and ventricular tachycardia. LGE also correlates with more sudden cardiac death risk factors in HCM patients.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Hypertrophic cardiomyopathy (HCM) is characterized by increased myocardial collagen and disarray.
- Late gadolinium enhancement (LGE) in cardiovascular magnetic resonance (CMR) visualizes myocardial scarring, often in HCM.
- LGE extent in HCM is linked to increased risk factors for sudden cardiac death.
Purpose of the Study:
- To characterize clinical features and sudden death risk factors in HCM patients.
- To investigate the relationship between LGE on CMR and these clinical factors.
Main Methods:
- 120 HCM patients underwent clinical evaluation and CMR with LGE assessment.
- Risk factors for sudden death, exercise capacity, and NT-proBNP levels were analyzed.
- Multivariate analysis identified predictors of LGE.
Main Results:
- 69% of patients showed LGE.
- LGE patients had greater left ventricular wall thickness, more frequent obstruction, and nonsustained ventricular tachycardia.
- LGE was associated with worse exercise capacity, higher NT-proBNP, and a greater number of sudden death risk factors.
Conclusions:
- Late gadolinium enhancement is a frequent finding in hypertrophic cardiomyopathy.
- Increased maximal left ventricular wall thickness and nonsustained ventricular tachycardia are associated with LGE.
- LGE in HCM correlates with elevated risk factors for sudden death and impaired functional status.
Background:
Hypertrophic cardiomyopathy (HCM) shows increased myocardial collagen and disarray. Late gadolinium enhancement in cardiovascular magnetic resonance (CMR) is observed in regions of increased myocardial collagen. The extent of late gadolinium enhancement has been associated with higher prevalence of risk factors of sudden death. The aim of the present study was to describe the clinical characteristics and the presence of risk factors for sudden death in a series of patients from 2 referral centers for HCM in relation to late gadolinium enhancement in CMR.
Methods And Results:
A total of 120 patients (47 +/- 16 years) were included. All patients fulfilled conventional criteria for HCM. A complete history and clinical examination were performed. Risk factors for sudden death were evaluated. A blinded CMR was performed with late gadolinium enhancement in the left ventricular short-axis orientation. NT pro B-type natriuretic protein (BNP) and C-reactive protein were determined in serum samples. A total of 83 patients (69%) showed late gadolinium enhancement. These patients had higher maximal left ventricular wall thickness (22 +/- 5 versus 17 +/- 3 mm, P < .001), showed more frequently obstruction (42% versus 16%, P = .006), nonsustained ventricular tachycardia (38% versus 8%, P = .001), worse exercise capacity (8 +/- 4 versus 10 +/- 4 METs, P = .003) and increased levels of NT BNP (656 [300-1948] versus 290 [122-948] pg/mL, P = .020). On multivariate analysis, maximal left ventricular wall thickness (P < .001) and nonsustained ventricular tachycardia (P = .011) remained associated with gadolinium-enhanced imaging. Number of risk factors for sudden death was associated with late gadolinium enhancement (OR 2.18, 95%CI 1.45-3.20, P < .001).
Conclusions:
Late gadolinium enhancement in CMR is a common finding in HCM. Increased maximal left ventricular wall thickness and nonsustained ventricular tachycardia are associated with late gadolinium enhancement. Associations with risk factors for sudden death and functional status are observed.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Imaging Studies for Cardiovascular System IV: CMRI
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
